Johnson Investment Counsel’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $478K | Buy |
11,209
+103
| +0.9% | +$4.6K | ﹤0.01% | 622 |
|
|
2026
Q1 | $535K | Sell |
11,106
-726
| -6% | -$33.9K | ﹤0.01% | 564 |
|
|
2025
Q4 | $573K | Hold |
11,832
| – | – | ﹤0.01% | 519 |
|
|
2025
Q3 | $558K | Sell |
11,832
-2,000
| -14% | -$96.5K | ﹤0.01% | 554 |
|
|
2025
Q2 | $668K | Buy |
13,832
+1,736
| +14% | +$88.7K | 0.01% | 485 |
|
|
2025
Q1 | $671K | Sell |
12,096
-1,750
| -13% | -$94.7K | 0.01% | 472 |
|
|
2024
Q4 | $668K | Sell |
13,846
-701
| -5% | -$35.6K | 0.01% | 469 |
|
|
2024
Q3 | $838K | Buy |
14,547
+4,288
| +42% | +$232K | 0.01% | 419 |
|
|
2024
Q2 | $498K | Sell |
10,259
-312
| -3% | -$15.1K | 0.01% | 497 |
|
|
2024
Q1 | $514K | Sell |
10,571
-398
| -4% | -$19.4K | 0.01% | 500 |
|
|
2023
Q4 | $545K | Buy |
10,969
+3,514
| +47% | +$172K | 0.01% | 465 |
|
|
2023
Q3 | $400K | Buy |
7,455
+148
| +2% | +$7.89K | 0.01% | 503 |
|
|
2023
Q2 | $394K | Buy |
7,307
+2,018
| +38% | +$109K | ﹤0.01% | 516 |
|
|
2023
Q1 | $288K | Sell |
5,289
-3,207
| -38% | -$156K | ﹤0.01% | 561 |
|
|
2022
Q4 | $411K | Sell |
8,496
-78
| -0.9% | -$3.42K | 0.01% | 493 |
|
|
2022
Q3 | $326K | Buy |
8,574
+78
| +0.9% | +$3.48K | ﹤0.01% | 519 |
|
|
2022
Q2 | $425K | Buy |
8,496
+1,779
| +26% | +$94.4K | 0.01% | 480 |
|
|
2022
Q1 | $345K | Sell |
6,717
-6,860
| -51% | -$354K | ﹤0.01% | 547 |
|
|
2021
Q4 | $680K | Buy |
13,577
+107
| +0.8% | +$5.29K | 0.01% | 399 |
|
|
2021
Q3 | $649K | Sell |
13,470
-9,006
| -40% | -$458K | 0.01% | 400 |
|
|
2021
Q2 | $1.18M | Sell |
22,476
-1,278
| -5% | -$66.7K | 0.02% | 302 |
|
|
2021
Q1 | $1.18M | Sell |
23,754
-1,850
| -7% | -$88.9K | 0.02% | 291 |
|
|
2020
Q4 | $1.24M | Sell |
25,604
-1,295
| -5% | -$63.9K | 0.02% | 265 |
|
|
2020
Q3 | $1.35M | Sell |
26,899
-465
| -2% | -$23.9K | 0.03% | 227 |
|
|
2020
Q2 | $1.4M | Sell |
27,364
-2,305
| -8% | -$112K | 0.03% | 217 |
|
|
2020
Q1 | $1.3M | Sell |
29,669
-3,010
| -9% | -$144K | 0.03% | 212 |
|
|
2019
Q4 | $1.64M | Sell |
32,679
-332
| -1% | -$15.6K | 0.03% | 223 |
|
|
2019
Q3 | $1.53M | Buy |
+33,011
| New | +$1.42M | 0.03% | 227 |
|
|
2019
Q1 | – | Sell |
-7,802
| Closed | -$338K | – | 618 |
|
|
2018
Q4 | $338K | Sell |
7,802
-154
| -2% | -$6.79K | 0.01% | 461 |
|
|
2018
Q3 | $355K | Sell |
7,956
-87
| -1% | -$3.72K | 0.01% | 492 |
|
|
2018
Q2 | $321K | Buy |
8,043
+25
| +0.3% | +$984 | 0.01% | 506 |
|
|
2018
Q1 | $321K | Buy |
8,018
+41
| +0.5% | +$1.71K | 0.01% | 513 |
|
|
2017
Q4 | $343K | Sell |
7,977
-151
| -2% | -$6.96K | 0.01% | 501 |
|
|
2017
Q3 | $404K | Buy |
8,128
+28
| +0.3% | +$1.35K | 0.01% | 458 |
|
|
2017
Q2 | $388K | Buy |
+8,100
| New | +$387K | 0.01% | 468 |
|
|
2016
Q3 | – | Sell |
-5,453
| Closed | -$228K | – | 585 |
|
|
2016
Q2 | $228K | Sell |
5,453
-3,463
| -39% | -$142K | 0.01% | 505 |
|
|
2016
Q1 | $358K | Buy |
8,916
+2,025
| +29% | +$81.4K | 0.01% | 405 |
|
|
2015
Q4 | $293K | Buy |
6,891
+355
| +5% | +$16.3K | 0.01% | 436 |
|
|
2015
Q3 | $310K | Buy |
+6,536
| New | +$333K | 0.01% | 427 |
|
Other funds holding SNY
DC
FRM
EIP
QCM
TI
MFG
TNB
SIS
SAM
Johnson Investment Counsel's SNY Position: Q2 2026 in Review
Johnson Investment Counsel increased its Sanofi (SNY) stake by 0.93% in Q2 2026, buying an estimated $4.6K and bringing the position to 11,209 shares worth $478K. The position accounts for ﹤0.01% of the portfolio, ranked #622.
Johnson Investment Counsel first reported a position in SNY in Q3 2015 and has held it in 39 quarters since. The position peaked at $1.64M in Q4 2019. 181 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Johnson Investment Counsel held 11,209 shares of Sanofi worth $478K as of Q2 2026.
- Johnson Investment Counsel bought 103 Sanofi shares in Q2 2026, an estimated $4.6K.
- Sanofi made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #622 holding.
- Johnson Investment Counsel first reported a position in Sanofi in Q3 2015 and has held it in 39 quarters since.
- Johnson Investment Counsel's Sanofi position peaked at $1.64M in Q4 2019.
- 181 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.